F8T-16137-70459
3 vaccinations
7 coded responses
37 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-05
Health check-in — day 0, dose 1Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-07-05
- 2021-10-04
-
2021-11-18
Dose 2 — Moderna
- 2021-11-18
- 2021-11-19
-
2021-11-20
Survey response — days 1–6 daily, dose 2MedDRA: Pregnancy, Vaginal haemorrhage — Feeling: Fair · Site: Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pregnancy spottingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-12-02
-
2021-12-09
Survey response — day 21, dose 2MedDRA: Haemorrhage in pregnancy — Feeling: GoodFree text: Pregnancy spottingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-16
-
2021-12-23
Survey response — day 35, dose 2MedDRA: Headache, Respiratory tract congestion — Feeling: GoodFree text: Headaches. CongestionMedDRA releases: 2024-11 · check-in free text available
- 2021-12-30
-
2022-02-17
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Preterm baby loss. CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-02-18
-
2022-02-22
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-13
Dose 3 — ModernaCo-administered: Flu
- 2022-10-14
- 2022-10-15
- 2022-10-16
-
2022-11-10
Survey response — day 28, dose 3MedDRA: Abdominal pain lower, Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Intense pain in lower abdomen for 5 days. Frequent headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Survey response — day 35, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Cold. Sore throat and runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
-
2023-01-12
Survey response — 3 months, dose 3MedDRA: Cough, Eye infection, Nasopharyngitis, Office visit — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-12
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-13
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-18 | Moderna | No |
| 3 | 2022-10-13 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-17 | Successful 2022-02-22 |
Participant prefers to complete VAERS report online |
| 2023-01-12 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Pregnancy spotting
Release 10 — day 21, dose 2
Symptoms: Pregnancy spotting
Release 10 — day 35, dose 2
Symptoms: Headaches. Congestion
Release 11 — 3 months, dose 2
Symptoms: Preterm baby loss. Covid
Release 12 — day 28, dose 3
Symptoms: Intense pain in lower abdomen for 5 days. Frequent headaches
Release 12 — day 35, dose 3
Symptoms: Cold. Sore throat and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal pain lower | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Haemorrhage in pregnancy | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
| SRO | Vaginal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release